Temasek joins US$150m funding for US biotech firm

Orchard Therapeutics will utilise the funding to register and commercialise their clinical programs.

Temasek joined the US$150m Series C financing led by New York-based hedge fund sponsor Deerfield Management for US biotech firm Orchard Therapeutics, an announcement revealed.

“We are pleased to have led this round of financing. We believe the company has generated compelling clinical data on products which have the potential to become breakthrough treatments for patients,” Deerfield Management principal Elise Wang said.

Orchard Therapeutics will utilise the fund in order for the firm’s advanced clinical programs to approach registration and commercialization. The completed deal will also back the clinical and preclinical development of the company’s rare disease gene therapy pipeline.

“We are advancing our pipeline of potentially transformative gene therapies in primary immune deficiencies and neurometabolic disorders to reach patients as quickly as possible,” Orchard CFO and cheif business officer Frank Thomas commented.

The firm holds offices in London, San Francisco, and Boston.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.


The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.


So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.